Serum IFN-γ and RNAemia temporal profiles as biomarkers of severe COVID-19 in solid organ transplant and immunocompetent patients

[1]  Ganlin Zhang,et al.  Serological response to COVID-19 vaccine and its predictors in patients with solid malignancies: A systematic review and meta-analysis of 16 cohort studies , 2022, Journal of Infection.

[2]  Yasser Fakri Mustafa,et al.  The deciphering of the immune cells and marker signature in COVID‐19 pathogenesis: An update , 2022, Journal of medical virology.

[3]  P. Gregersen,et al.  The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies , 2022, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M. Edmond,et al.  Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: A systematic literature review and meta-analysis , 2022, Journal of Infection.

[5]  E. Coccia,et al.  Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection , 2021, bioRxiv.

[6]  J. Richards,et al.  Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortality , 2021, medRxiv.

[7]  J. Casanova,et al.  SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4 , 2021, The Journal of experimental medicine.

[8]  Steven M. Holland,et al.  Autoantibodies against type I IFNs in patients with life-threatening COVID-19 , 2020, Science.

[9]  J. Greenbaum,et al.  Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity , 2020, Cell.

[10]  R. Trimble COVID-19 Dashboard , 2020 .